Which hedge funds own CLDX? CELLDEX THERAPEUTICS INC NEW, Q2 2026 13F holders
55 tracked hedge funds disclosed a position in CLDX (CELLDEX THERAPEUTICS INC NEW) in their Q2 2026 13F filings, worth $990.7m in total. The largest holder by portfolio weight is Kynam Capital Management, LP at 10.9% of its book. 13 opened a new position this quarter: Verdad Advisers, LP, Integral Health Asset Management, LLC, Montanova Capital, LLC, Seven Grand Managers, LLC. 10 exited: Vestal Point Capital, LP, Silverarc Capital Management, LLC, Scientech Research LLC.
- 55
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 13
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 10
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $25.5m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $54.2m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $991m
- Combined value Sum of the holders' reported positions in the security.
- 4.4%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Vestal Point Capital, LP | 1.1% | $38.8m |
| Silverarc Capital Management, LLC | 0.7% | $5.7m |
| Scientech Research LLC | 0.3% | $301k |
| EntryPoint Capital, LLC | 0.07% | $236k |
| Twinbeech Capital LP | 0.04% | $363k |
| ArrowMark Colorado Holdings LLC | 0.02% | $793k |
| Tudor Investment Corp ET AL | 0.01% | $1.1m |
| Citadel Advisors LLC | 0.0% | $6.4m |
| Jain Global LLC | 0.0% | $246k |
| Walleye Capital LLC | 0.0% | $258k |
Ownership over time
Who discovered CLDX first? Beta
The run: Q1 2020 → Q3 2021, ×33
| Ikarian Capital, LLC high conviction | Q2 2020 | – | +4.9 pts |
| Opaleye Management Inc. high conviction | Q2 2020 | – | +2.5 pts |
| Eversept Partners, LP | Q2 2020 | – | +1.2 pts |
| Logos Global Management LP high conviction | Q2 2020 | – | +1.0 pts |
| Sabby Management, LLC | Q2 2020 | – | – |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.